Literature DB >> 25572729

Rhinosinusitis and asthma: a very long engagement.

A Licari1, S Caimmi1, L Bosa1, A Marseglia1, G L Marseglia1, D Caimmi1.   

Abstract

Upper and lower airways may be considered as a unique entity, interested by coexisting inflammatory processes that share common etiopathogenic mechanisms. Previous studies have strongly demonstrated a relationship between rhinosinusitis and asthma. This has led to the introduction of the concept of “United Airways”, which has also been included in the WHO document Allergic Rhinitis and its Impact on Asthma (ARIA); this concept has important consequences also on the treatment of these disorders. To better summarize the evident connection between upper and lower airway disease we decided to describe it as a multilayered construction, each level pointing out more deeply the relationship between these entities.

Entities:  

Mesh:

Year:  2014        PMID: 25572729     DOI: 10.1177/039463201402700405

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  9 in total

1.  [Guideline for "rhinosinusitis"-long version : S2k guideline of the German College of General Practitioners and Family Physicians and the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery].

Authors:  B A Stuck; A Beule; D Jobst; L Klimek; M Laudien; M Lell; T J Vogl; U Popert
Journal:  HNO       Date:  2018-01       Impact factor: 1.284

2.  Paranasal sinus opacification at MRI in lower airway disease (the HUNT study-MRI).

Authors:  Aleksander Grande Hansen; Anne-Sofie Helvik; Wenche Moe Thorstensen; Ståle Nordgård; Arnulf Langhammer; Vegard Bugten; Lars Jacob Stovner; Heidi Beate Eggesbø
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-10-26       Impact factor: 2.503

3.  Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives.

Authors:  Amelia Licari; Sara Manti; Riccardo Castagnoli; Giuseppe Fabio Parisi; Carmelo Salpietro; Salvatore Leonardi; Gian Luigi Marseglia
Journal:  Paediatr Drugs       Date:  2019-08       Impact factor: 3.930

Review 4.  An Update on Anti-IgE Therapy in Pediatric Respiratory Diseases.

Authors:  Amelia Licari; Riccardo Castagnoli; Elisa Panfili; Alessia Marseglia; Ilaria Brambilla; Gian Luigi Marseglia
Journal:  Curr Respir Med Rev       Date:  2017-03

5.  Fungal Microbiota in Chronic Airway Inflammatory Disease and Emerging Relationships with the Host Immune Response.

Authors:  Irene Zhang; Steven D Pletcher; Andrew N Goldberg; Bridget M Barker; Emily K Cope
Journal:  Front Microbiol       Date:  2017-12-12       Impact factor: 5.640

6.  Upper airway involvement in bronchiectasis is marked by early onset and allergic features.

Authors:  Michal Shteinberg; Najwan Nassrallah; Jenny Jrbashyan; Nechama Uri; Nili Stein; Yochai Adir
Journal:  ERJ Open Res       Date:  2018-01-19

Review 7.  The Nose and the Lung: United Airway Disease?

Authors:  Amelia Licari; Riccardo Castagnoli; Chiara Francesca Denicolò; Linda Rossini; Alessia Marseglia; Gian Luigi Marseglia
Journal:  Front Pediatr       Date:  2017-03-03       Impact factor: 3.418

Review 8.  Measuring inflammation in paediatric severe asthma: biomarkers in clinical practice.

Authors:  Amelia Licari; Sara Manti; Riccardo Castagnoli; Salvatore Leonardi; Gian Luigi Marseglia
Journal:  Breathe (Sheff)       Date:  2020-03

Review 9.  Novel therapeutic targets for allergic airway disease in children.

Authors:  Alessandro Giallongo; Giuseppe Fabio Parisi; Amelia Licari; Giulio Pulvirenti; Caterina Cuppari; Carmelo Salpietro; Gian Luigi Marseglia; Salvatore Leonardi
Journal:  Drugs Context       Date:  2019-07-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.